News - Novartis

Filter

Current filters:

Novartis

Popular Filters

380 to 385 of 385 results

UK’s NICE says “no” to Novartis Tasigna and B-MS Sprycel, but better news on Afinitor

06-05-2011

The UK’s drug rationing body the National Institute for Health and Clinical Excellence (NICE) yesterday…

AfinitorBristol-Myers SquibbGlivecNovartisOncologyPharmaceuticalPricingRegulationSprycelTasigna

New study reveals risks with Roche’s Avastin for wet AMD versus Lucentis

05-05-2011

A new Medicare analysis conducted by Johns Hopkins University in the USA was presented yesterday at the…

AvastinLucentisNovartisOphthalmicsPharmaceuticalResearchRoche

Novartis gains EU approval for combo drug Rasilamlo to treat high BP

29-04-2011

Swiss drug major Novartis (NOVN: VX) says that Rasilamlo, a single-pill combination of aliskiren and…

Cardio-vascularEuropeNovartisPharmaceuticalRasilamloRegulation

Vaccine to halt Alzheimer's could be available within few years

26-04-2011

A vaccine that has the potential to stop Alzheimer's disease progression could be available within a…

BiotechnologyCytos BiotechnologyNeurologicalNovartisPharmaceuticalResearchVaccines

Novartis withdraws MA for Joicela; gets “no” from UK's NICE for Afinitor

20-04-2011

There were two pieces of negative news for Swiss drug major Novartis (NOVN: VX) yesterday, when the company…

AfinitorEuropeJoicelalumiracoxibNeurologicalNovartisOncologyPharmaceuticalRegulation

380 to 385 of 385 results

Back to top